<DOC>
	<DOCNO>NCT00695630</DOCNO>
	<brief_summary>An increase utilization anesthesia sedation medication non-anesthesiologists , include dentist , grow dramatically . This prompt , part , need pharmacological tool address high level fear anxiety dental care among US population evidence oral health disparity among fearful . Given prevalence dental fear general population various population great burden oral disease , effective sedation technique need safe effective hand general dentist make `` front line '' effort reduce oral health disparity . This study determine whether , compare saline placebo , single intraoral submucosal administration benzodiazepine antagonist flumazenil ( 0.2 mg ) capable attenuate 10 minute less central nervous system ( CNS ) depression produce paradigm stack sublingual dosing triazolam ( 3 dose 0.25 mg 90 minute ) .</brief_summary>
	<brief_title>Flumazenil Reversal Oral Triazolam</brief_title>
	<detailed_description />
	<mesh_term>Flumazenil</mesh_term>
	<criteria>ASA I Use benzodiazepine , anxiolytic medication would interact either triazolam 's flumazenil 's metabolism clinical effect ( include herbal ) within four week study Body mass index ( BMI ) less 15 kg/m2 great 30 kg/m2 Pregnancy currently use pharmacologic method birth control Allergy sensitivity benzodiazepine History seizure disorder ; AND Chronic tobacco use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>conscious sedation</keyword>
	<keyword>dental anxiety/drug therapy</keyword>
	<keyword>behavior/drug effect</keyword>
</DOC>